Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Inherited Creutzfeldt-Jakob disease (fCJD) is an autosomal dominant prionopathy caused by pathogenic variants in PRNP. Familial cases have been reported in multi-generation pedigrees, including a kindred with five affected members carrying a codon 178 missense substitution and a 24-bp deletion in the octapeptide repeat region, implicating D178N in disease pathogenesis (PMID:1357594). A large cluster of African American kindreds demonstrated 8 confirmed and 13 suspected cases across seven generations, underscoring AD segregation and enabling predictive testing (PMID:27997483).
Genetic evidence encompasses over 500 reported PRNP mutations in fCJD, including missense changes (e.g., P102L, R148H, V180I) and octapeptide repeat insertions, with consistent co-segregation in unrelated families and absence in healthy controls (PMID:12420099; PMID:16314483). The R148H variant (c.443G>A (p.Arg148His)) has been documented as de novo or inherited with complete penetrance except for rare late-onset nonpenetrance (PMID:16314483).
Functional studies support a toxic gain-of-function mechanism. Molecular dynamics and NMR of D178N and E200K variants reveal minimal global folding changes but altered surface electrostatics and helix stability favoring beta-rich oligomerization (PMID:10954699; PMID:11775003). Cell models of E200K demonstrate aberrant glycosylation and impaired trafficking, leading to proteasome-resistant PrP accumulation (PMID:10438517; PMID:10934164).
Incomplete penetrance has been observed for codon 188 variants (e.g., T188K) where an obligate carrier remained asymptomatic at age 79, indicating modifier effects of codon 129 and other factors (PMID:18478114).
Together, genetic and experimental findings establish PRNP mutations as definitively causal for fCJD. Clinical utility includes genetic counseling, presymptomatic testing, and informed decision-making for at-risk relatives. Key Take-home: AD PRNP variants drive misfolding and neurodegeneration in fCJD, warranting early genetic evaluation and family screening.
Gene–Disease AssociationDefinitiveNumerous case reports in >500 pedigrees over >30 y; autosomal dominant segregation in multi-generation families; consistent functional studies Genetic EvidenceStrong
Functional EvidenceModerateIn vitro and in vivo models show misfolding, abnormal glycosylation, proteasomal resistance aligning with dominant toxic gain‐of‐function |